Curr Opin Investig Drugs. 2005 Jun;6(6):597-604.

Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.

Source

Division of Hematology, Department of Medicine, Providence Health Care at St Paul's Hospital, University of British Columbia, 440-1144 Burrard Street, Vancouver, Canada. hleitch@providencehematology.com

Abstract

Immunity against tumor antigens, including the passive transfer of humoral (antibody-based) immunity or cellular immunity in the form of cytotoxic T-lymphocyte clones, has been exploited for the treatment of non-Hodgkin's lymphoma and other B-cell malignancies in recent years. In many strategies, the idiotype expressed on B-cell malignancies is the antigen used to induce active immunity. Early studies using purified idiotype, immune adjuvant and cytokines to induce anti-idiotype immunity have demonstrated that these methods are safe and potentially effective, and they are now being tested in prospective, randomized clinical trials. Methods for improvement include recombinant sources of idiotype, DNA vectors, enhancement of antigen delivery and presentation by using dendritic cells, boosting immune help through the use of cytokine delivery or foreign antigens, and blocking negative regulators. The goal of this approach is to induce lasting and individualized immunity against B-cell malignancies that is readily available and cost-effective.

PMID:: 15988911; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Cancer Vaccines

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. [Haematologica. 2002]
Review Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA, Neelapu SS, Kwak LW, Biragyn A. Haematologica. 2002 Sep; 87(9):989-1001.
Review Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma. [Curr Gene Ther. 2005]
Review Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
Ruffini PA, Di Nicola M, Carlo-Stella C, Siena S, Gianni AM. Curr Gene Ther. 2005 Oct; 5(5):511-21.
Review The role of idiotype vaccines in the treatment of human B-cell malignancies. [Expert Rev Vaccines. 2004]
Review The role of idiotype vaccines in the treatment of human B-cell malignancies.
Bendandi M. Expert Rev Vaccines. 2004 Apr; 3(2):163-70.
Review Vaccine therapy for B-cell lymphomas: next-generation strategies. [Hematology Am Soc Hematol Educ...]
Review Vaccine therapy for B-cell lymphomas: next-generation strategies.
Neelapu SS, Kwak LW. Hematology Am Soc Hematol Educ Program. 2007; :243-9.
Review Current status of immunotherapy in B cell malignancies. [Curr Drug Targets. 2006]
Review Current status of immunotherapy in B cell malignancies.
Kofler DM, Mayr C, Wendtner CM. Curr Drug Targets. 2006 Oct; 7(10):1371-4.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.
Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.
Curr Opin Investig Drugs. 2005 Jun ;6(6):597-604.

PubMed
Pretreatment with ursodeoxycholic acid (UDCA) as a novel pharmacological interve...
Pretreatment with ursodeoxycholic acid (UDCA) as a novel pharmacological intervention in hepatobiliary scintigraphy.
Yonsei Med J. 2005 Jun 30 ;46(3):394-8.

PubMed
Life-threatening third-trimester hemorrhage following a vanishing twin phenomeno...
Life-threatening third-trimester hemorrhage following a vanishing twin phenomenon in early pregnancy.
Ultrasound Obstet Gynecol. 2005 Aug ;26(2):196-7; discussion 197.

PubMed
A combined genomewide linkage scan of 1,233 families for prostate cancer-suscept...
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.
Am J Hum Genet. 2005 Aug ;77(2):219-29. Epub 2005 Jun 29 .

PubMed
Structure of a Na+/H+ antiporter and insights into mechanism of action and regul...
Structure of a Na+/H+ antiporter and insights into mechanism of action and regulation by pH.
Nature. 2005 Jun 30 ;435(7046):1197-202.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: